Biologic roles of gangliosides GM3 and GD3 in the attachment of human melanoma cells to extracellular matrix proteins

被引:19
|
作者
Nakano, J
Yasui, H
Lloyd, KO
Muto, M
机构
[1] Yamaguchi Univ, Sch Med, Dept Dermatol, Ube, Yamaguchi 7558505, Japan
[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
关键词
cell adhesion; collagen; fibronectin; laminin;
D O I
10.1038/sj.jidsp.5640204
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The biologic functions of gangliosides G(M3) and G(D3) in the attachment of human melanoma cells to extracellular matrix proteins (type I and TV collagens, fibronectin, and laminin) were investigated by using the G(D3)-deficient mutant clone (SK-MEL-28-N1) and the parent cell line SK-MEL28, SK-MEL-28-N1 (N1) (high G(M3) expression: G(M3), 97.3%; G(D3), 0%) Was selected by treating SK-MEG 28 (high G(D3) but low G(M3): G(M3), 6.5%, G(D3), 93.5%) with an anti-G(D3) monoclonal antibody (R24) and rabbit complement and subsequent subcloning of the surviving cells. The N1 clone showed significantly higher ability to adhere to type I and IV collagens and laminin than the parent clone SK-MEL-28, In the N1 clone, the expression of alpha 2 beta 1 and alpha 3 beta 1 integrin receptors was increased, whereas in SK-MEL28, their expression was very low or undetectable. The treatment with monoclonal antibodies directed specifically to G(D3) expressed on SK-MEL28 inhibited the cell attachment to type TV collagen (33% inhibition of control), fibronectin (59%), and laminin (71%). These findings suggest that gangliosides G(M3) (by influencing integrin receptor levels) and G(D3) (by interacting directly with matrix proteins) might play some functional roles in attachment to extracellular matrix proteins and thereby enhance the metastatic potency of melanoma cells.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 50 条
  • [21] Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
    Yanagisawa, Makoto
    Yoshimura, Saori
    Yu, Robert K.
    ASN NEURO, 2011, 3 (02): : 69 - 74
  • [22] Postprandial change in GD3 and GM3 ganglioside species in type 2 diabetes.
    Serna, Irma Magly Rivas
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 2021, 98 : 278 - 278
  • [23] Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells
    Zou, W
    Borrelli, S
    Gilbert, M
    Liu, TM
    Pon, RA
    Jennings, HJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) : 25390 - 25399
  • [24] DISIALOGANGLIOSIDES GD2 AND GD3 ARE INVOLVED IN THE BINDING OF HUMAN-MELANOMA CELLS TO THE CELL ATTACHMENT SITE OF FIBRONECTIN
    CHERESH, DA
    PIERSCHBACHER, MD
    HARPER, JR
    SCHULZ, G
    HERZIG, MA
    REISFELD, RA
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 795 - 795
  • [25] Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3
    Shibuya, Hidenobu
    Hamamura, Kazunori
    Hotta, Hiroshi
    Matsumoto, Yasuyuki
    Nishida, Yoshihiro
    Hattori, Hisashi
    Furukawa, Keiko
    Ueda, Minoru
    Furukawa, Koichi
    CANCER SCIENCE, 2012, 103 (09) : 1656 - 1664
  • [26] EXPRESSION OF THE GANGLIOSIDES GD3 AND GD2 ON LYMPHOCYTES IN TISSUE-SECTIONS OF MELANOMA
    HERSEY, P
    JAMAL, O
    PATHOLOGY, 1989, 21 (01) : 51 - 58
  • [27] INHIBITION OF METASTASES OF A HUMAN-MELANOMA XENOGRAFT BY MONOCLONAL-ANTIBODY TO THE GD2 GD3 GANGLIOSIDES
    ILIOPOULOS, D
    ERNST, C
    STEPLEWSKI, Z
    JAMBROSIC, JA
    RODECK, U
    HERLYN, M
    CLARK, WH
    KOPROWSKI, H
    HERLYN, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (06) : 440 - 444
  • [28] GANGLIOSIDE GD3 SHEDDING BY HUMAN-MALIGNANT MELANOMA-CELLS
    BERNHARD, H
    ZUMBUSCHENFELDE, KHM
    DIPPOLD, WG
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) : 155 - 160
  • [29] GD3 AND O-ACETYL GD3 GANGLIOSIDES IN LYMPHOCYTES-T - PREFERENTIAL EXPRESSION OF O-ACETYL GD3 IN CD4(+)-CELLS
    REIVINEN, J
    HOLTHOFER, H
    MIETTINEN, A
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A88 - A88
  • [30] Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosides
    Ma, R
    Koulov, A
    Moulton, C
    Basu, M
    Banerjee, S
    Goodsonm, H
    Basu, S
    GLYCOCONJUGATE JOURNAL, 2003, 20 (05) : 319 - 330